Stock screener

AXSM

Conviction 100HealthcareScan · Thu, Jun 25, 2026
Three black crows
AXSM$237.24-0.29%
ResistanceSupportVol 14Insider sell
63 bars
2
3
Vol MA14 862.17K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Axsome Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.axsome.com
Price237.24
Change-0.29%
Gap+0.08%
Rel volume2.22×
Avg volume795.06K
Avg $ vol191.58M
SMA 20241.30
SMA 50222.93
SMA 200170.45
Price vs 50+6.42%
Price vs 200+39.19%
MA stackbullish
50/200 cross
Supertrendup · 228.59
RSI (14)50
MACD hist-2.39
MACD crossbear · 3d
Stoch %K / %D28 / 39
ADX (14)37
+DI / −DI22 / 16
RSI divergence
MACD divergence
ATR %+3.63%
ADR %3.58%
52w high255.17
52w low100.39
From 52w high-7.03%
Above 52w low+136.32%
New 52w highNo
SqueezeOff
Bollinger width15.76%
%B0.39
Donchian pos46.68%
Donchian high260.19
Donchian low217.15
AVWAP (52w high)244.14
vs AVWAP high-2.83%
AVWAP (52w low)170.34
vs AVWAP low+39.27%
OBV trendFlat
Chaikin MF (20)-0.25
Today vs 20d2.22×
Avg vol (14d)862.17K
Avg vol (20d)795.06K
Avg $ vol (20d)191.58M
Market cap12.21B
RS 3m (vs SPY)+37.61%
RS 6m (vs SPY)+48.12%
RS line new highNo
Trend template8/8
Technical rank80.8
1 week-5.92%
1 month+1.30%
3 months+46.64%
6 months+53.35%
1 year+127.55%
YTD+32.77%
P/E-66.65
P/B223.65
P/S19.12
P/FCF-130.03
EPS-3.68
Div yield
ROE-335.56%
ROA-25.67%
Debt/Eq3.44
Current1.39
EV/EBITDA
Gross margin
Net margin-28.69%
Rev growth65.55%
EPS growth36.22%
Price target266.69
Target upside12.41%
Analyst ratingBuy
Institutional83.05%
Ent. value12.09B
Revenue191.2M
Net income-64.54M
Gross profit
Free cash flow-93.89M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out51.46M
Employees925
ListedThu, Nov 19, 2015
Free float40.27M
Float %78.7%
Short interest3.09M
Days to cover5.0d
Short volume33.8%
Squeeze score55 / 100
Next earningsMon, Aug 3, 2026 (39d)
EPS forecast$1.00 · 6 est
Last EPS vs est−$1.26 vs −$0.85
Last surprise-48.2% miss
Setup gradeA+
Conviction100 / 100
Pattern quality
Tech rank80.8 / 100
Group rank50 / 100
Status lane
Setup direction
Pattern family
Resistance
Support
Days since event
Candle confirmThree black crows
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in AXSM

All disclosures →
No recent disclosed trades by Congress in AXSM. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AXSM · 3 buys · 5 sells

InsiderSideShares
Coleman Mark
Director · Common Stock · 2026-06-10
Sell643
Mahony Susan
Director · Common Stock · 2026-06-10
Sell300
Mahony Susan
Director · Common Stock · 2026-06-09
Sell300
Saad Mark E
Director · Common Stock · 2026-06-08
Exercise1.43K
JEFFS ROGER
Director · Common Stock · 2026-06-08
Exercise1.43K
Coleman Mark
Director · Common Stock · 2026-06-08
Other
Mahony Susan
Director · Restricted Stock Units · 2026-06-08
Exercise1.43K
Mahony Susan
Director · Common Stock · 2026-06-08
Exercise1.43K
Saad Mark E
Director · Common Stock · 2026-06-08
Other
Saad Mark E
Director · Restricted Stock Units · 2026-06-08
Exercise1.43K

SEC filings

EDGAR filings in AXSM · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.